Research Progresses in Understanding the Pathophysiology of Moyamoya Disease

Area of Science:

• Neurology
• Genetics
• Vascular Biology

Background:

• The exact cause of moyamoya disease (MMD) is unknown, though inflammatory molecules and genetic factors are suspected.
• While RNF213 gene mutations are strongly linked to MMD in East Asians, the functional mechanisms remain elusive.
• MMD is likely a complex, heterogeneous disorder influenced by multiple genetic and environmental factors.

Purpose of the Study:

• To explore the current understanding of MMD pathogenesis, focusing on genetic and inflammatory pathways.
• To highlight the need for further research into the mechanisms underlying MMD.
• To emphasize the growing importance of developing better risk stratification systems for MMD.

Main Methods:

• Review of existing literature on MMD pathogenesis, genetics, and associated molecular markers.
• Analysis of the role of inflammatory molecules (cytokines, chemokines, growth factors) in MMD.
• Examination of genetic associations, particularly the RNF213 gene, in MMD etiology.

Main Results:

• Evidence suggests a role for abnormal angiogenesis driven by inflammatory processes in MMD.
• Genetic factors, especially RNF213 mutations, play a significant role, particularly in specific populations.
• Current knowledge is insufficient to fully explain MMD pathophysiology.

Conclusions:

• MMD research is in its early stages, indicating a complex and multifactorial disease.
• Understanding the interplay of genetic and environmental factors is crucial for unraveling MMD.
• Developing advanced risk stratification systems is essential for personalized MMD interventions.